TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
On April 6th, 2017, on the 100 year anniversary of America’s entry into World War I, Donald Trump launched airstrikes against the Syrian government; in retaliation for a gas attack supposedly perpetrated by Assad. There was no investigation, not even a hack job of a frame up like we had in 2003. The evidence we Read More…
Whatever one’s views on Syrian president Bashar al-Assad, the whole world (with the exception of the establishment media) was in shock when Donald Trump committed a flagrant act of aggression against the government of Syria. There are many indications that this act will not contribute to Syria’s security or the safety and security of the wider international Read More…
President Trump earned neocon applause for his hasty decision to attack Syria and kill about a dozen Syrians, but his rash act has all the earmarks of a “wag the dog” moment. Just two days after news broke of an alleged poison-gas attack in northern Syria, President Trump brushed aside advice from some U.S. intelligence analysts Read More…
The United States finds its increasingly clumsy, circular foreign policy looping back once again to accusations of “weapons of mass destruction” being inexplicably used against a civilian population, this time in Syria’s northern city of Idlib currently serving as the de facto capital of terrorist organizations including various Al Qaeda affiliates, most notably the US Read More…
Before I lay down what will inevitably be experienced by some as an attack, it behooves us to recalibrate expectations. There are those that will begin commenting twenty seconds after a 2000 word article has gone public, mocking positions the author has never taken in any of his/her writings, writing off anyone who dares disagree Read More…
After it waged a veritable war against cannabis legalization in Arizona, coughing up half a million dollars for the campaign, Insys Therapeutics recently announced the ultimate victory has finally come to fruition: the DEA approved one of the company’s groundbreaking pharmaceuticals — synthetic marijuana — to be listed as a Schedule II substance. “Insys gave $500,000 last Read More…